SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
22-May-23 9:18 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-May-23 | Payment of Exercise | 5,447 | $0.87 | $4,738.89 | (3%) 186.02K to 180.57K | |
26-Jan-23 5:16 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-23 | Payment of Exercise | 9,608 | $1.26 | $12,106.10 | (5%) 195.63K to 186.02K | 9% |
20-May-22 4:27 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-May-22 | Payment of Exercise | 6,127 | $1.40 | $8,577.80 | (3%) 201.75K to 195.63K | |
26-Jan-22 4:31 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-22 | Payment of Exercise | 9,607 | $1.13 | $10,855.90 | (5%) 211.36K to 201.75K | (2%) |
20-May-21 4:06 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-May-21 | Payment of Exercise | 6,467 | $3.12 | $20,177.00 | (3%) 217.83K to 211.36K | 2% |
26-Jan-21 7:03 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-21 | Payment of Exercise | 9,605 | $4.46 | $42,838.30 | (4%) 227.43K to 217.83K | (3%) |
20-May-20 9:49 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 18-May-20 | Grant | 71,550 | -- | -- | 46% 155.88K to 227.43K | |
30-Jan-20 5:39 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 28-Jan-20 | Payment of Exercise | 9,148 | $7.00 | $64,036.00 | (6%) 165.03K to 155.88K | |
28-Jan-19 5:49 PM View: | Rvl Pharmaceuticals Plc (RVLP) | 24-Jan-19 | Grant | 104,849 | -- | -- | 174% 60.18K to 165.03K |